Royal Marsden Hospital | GenomeWeb

Royal Marsden Hospital

A UK researcher has streamlined how women at her hospital with ovarian cancer seek genetic testing.

The researchers reported that BRCA2 was the most commonly mutated germline DNA-repair gene in their cohort.

A new study suggests ctDNA in post-treatment blood samples may help predict relapse in early stage breast cancer patients treated with chemotherapy and surgery.

NEW YORK (GenomeWeb News) – A consortium of research centers led by the Institute of Cancer Research, London will partner with Illumina to launch a new sequencing-based testing program to analyze genetic mutations in cancer patients, the Wellcome Trust said today.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.